158
Participants
Start Date
October 13, 2020
Primary Completion Date
June 30, 2022
Study Completion Date
October 15, 2022
VS-505
4 dosages of experimental drug
Sevelamer Carbonate
Active Comparator
Peking University People's Hospital, Beijing
Peking University Third Hospital, Beijing
Zhongshan Hospital Xiamen University, Xiamen
Affiliated Hospital of Guilin Medical University, Guilin
The Third Hospital of Hebei Medical University, Shijiazhuang
The Second Affiliated Hospital of Xingtai Medical College, Xingtai
Renmin Hospital of Wuhan University, Wuhan
The Second People's Hospital of Changzhou, Changzhou
The Second Affiliated Hospital of Nanjing Medical University, Nanjing
Affiliated Hospital of Nantong University, Nantong
Wuxi People's Hospital, Wuxi
Northern Jiangsu People's Hospital, Yangzhou
Jilin Province People's Hospital, Changchun
The Second Hospital of Jilin University, Changchun
Dalina Municipal Central Hospital, Dalian
The First Hospital of Dalian Medical University, Dalian
The Second Hospital of Dalian Medical University, Dalian
Shanghai General Hospital, Shanghai
Shanghai Tenth People's Hospital, Shanghai
Xinhua Hospital Affiliated to Shanghai Jiao Tong Universiity School of Medcine, Shanghai
The Second Hospital of Shanxi Medical University, Taiyuan
Tianjin People's Hospital, Tianjin
Zhejiang Provincial People's Hospital, Hangzhou
Shanghai Alebund Pharmaceuticals Limited
INDUSTRY